Growth Metrics

Evolent Health (EVH) Receivables - Net (2016 - 2026)

Evolent Health has reported Receivables - Net over the past 11 years, most recently at $309.9 million for Q4 2025.

  • For Q4 2025, Receivables - Net fell 26.38% year-over-year to $309.9 million; the TTM value through Dec 2025 reached $309.9 million, down 26.38%, while the annual FY2025 figure was $309.9 million, 26.38% down from the prior year.
  • Receivables - Net for Q4 2025 was $309.9 million at Evolent Health, down from $408.1 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $472.4 billion in Q4 2023 and troughed at $127.7 million in Q2 2022.
  • A 5-year average of $23.9 billion and a median of $334.8 million in 2025 define the central range for Receivables - Net.
  • Biggest five-year swings in Receivables - Net: soared 175429.54% in 2023 and later plummeted 99.91% in 2024.
  • Year by year, Receivables - Net stood at $171.5 million in 2021, then surged by 56.91% to $269.1 million in 2022, then soared by 175429.54% to $472.4 billion in 2023, then plummeted by 99.91% to $420.9 million in 2024, then decreased by 26.38% to $309.9 million in 2025.
  • Business Quant data shows Receivables - Net for EVH at $309.9 million in Q4 2025, $408.1 million in Q3 2025, and $359.8 million in Q2 2025.